Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Classical pharmacology"'
Autor:
Sam R J Hoare
Publikováno v:
SLAS Discovery. 26:835-850
The analysis framework used to quantify drug potency in vitro (e.g., Kd or Ki) was initially developed for classical pharmacology bioassays, for example, organ bath experiments testing moderate-affinity natural products. Modern drug discovery can inf
Publikováno v:
Drug Discovery Today. 26:887-901
Research and development (R&D) productivity across the pharmaceutical industry has received close scrutiny over the past two decades, especially taking into consideration reports of attrition rates and the colossal cost for drug development. The resp
Publikováno v:
Hughes, B, Elliott, R, Dawson, J C & Carragher, N O 2021, ' High content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need ', Cell Chemical Biology . https://doi.org/10.1016/j.chembiol.2021.02.015
Conventional thinking in modern drug discovery postulates that the design of highly selective molecules which act on a single disease-associated target will yield safer and more effective drugs. However, high clinical attrition rates and lack of prog
Autor:
J. Willem M. Nissink, Jonathan B. Baell, Francis S. Willard, Ina Rothenaigner, Jonathan Z. Sexton, Douglas S. Auld, Jayme L. Dahlin, John Strelow, Michael A. Walters, Bruce K. Hua, Steve Haney, Lori Ferrins, Jarrod Walsh, Bridget K. Wagner, Jonathan A. Lee, Kamyar Hadian
Publikováno v:
Cell Chem. Bio. 28, 356-370 (2021)
Cell Chem Biol
Cell Chem Biol
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity (“nuisance compounds”) are routinely encountered in cellular assays, including phenotypic and high-content screening assays. Much is known regarding compound-depen
Autor:
Samreen K. Syed, David Gene Barrett, Francis S. Willard, Karen Leigh Cox, Dirk Tomandl, Alexander M. Efanov, Luyan Song
Publikováno v:
ASSAY and Drug Development Technologies. 19:27-37
Phenotypic screening is a neoclassical approach for drug discovery. We conducted phenotypic screening for insulin secretion enhancing agents using INS-1E insulinoma cells as a model system for pancreatic beta-cells. A principal regulator of insulin s
Publikováno v:
Drug Discovery Today. 25:1998-2005
Investment in phenotypic drug discovery has led to increased demand for rapid and robust target deconvolution to aid successful drug development. Although methods for target identification and mechanism of action (MoA) discovery are flourishing, they
Autor:
Adam Zweifach, Haim Bar
Publikováno v:
SLAS Discovery. 25:1000-1008
The assay metric Z' has come to play a critical gatekeeping role in determining whether high-throughput assays can be performed. While Z' is commonly required to be > 0.5, this expectation is not well supported. Requiring Z' > 0.5 likely prevents man
Publikováno v:
Drug Discov. Today 25, 1348-1361 (2020)
While target-based drug discovery strategies rely on the precise knowledge of the identity and function of the drug targets, phenotypic drug discovery (PDD) approaches allow the identification of novel drugs based on knowledge of a distinct phenotype
Autor:
Elisabeth Bäck, Jörgen Östling, Mei Ding, Christopher McCrae, Christian Tyrchan, Steffen Schubert
Publikováno v:
SLAS Discovery. 25:634-645
Human rhinovirus (RV) is the most common cause of acute upper respiratory tract infections and has recently been shown to play a significant role in exacerbations of asthma and chronic obstructive pulmonary disease (COPD). There is a significant unme
Autor:
John H. Ryan, Andrew G. Riches, Snigdha Tiash, Christopher J.S. Hart, Tina S. Skinner-Adams, Jake Saunders
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance
International Journal for Parasitology: Drugs and Drug Resistance, Vol 12, Iss, Pp 60-67 (2020)
International Journal for Parasitology: Drugs and Drug Resistance, Vol 12, Iss, Pp 60-67 (2020)
Giardia duodenalis, the most prevalent human intestinal parasite causes the disease, giardiasis. On an annual basis G. duodenalis infects ~1 billion people, of which ~280 million develop symptomatic disease. Giardiasis can be severe and chronic, caus